Mesenchymal stromal cells prolong the lifespan in a rat model of amyotrophic lateral sclerosis

References

• Rowland LP. Diagnosis of amyotrophic lateral sclerosis. J Neurol Sci. 1998;160(Suppl 1):S6–24.
   Google Scholar
• Bento-Abreu A, Van Damme P, Van Den Bosch L, Robberecht W. The neurobiology of amyotrophic lateral sclerosis. Eur J Neurosci. 2010;31:2247–65.
   PubMed Web of Science ®Google Scholar
• Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, . Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59–62.
   PubMed Web of Science ®Google Scholar
• Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, . Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science. 1994;264:1772–5.
   PubMed Web of Science ®Google Scholar
• Nagano I, Ilieva H, Shiote M, Murakami T, Yokoyama M, Shoji M, . Therapeutic benefit of intrathecal injection of insulin-like growth factor-1 in a mouse model of amyotrophic lateral sclerosis. J Neurol Sci. 2005;235:61–8.
   PubMed Web of Science ®Google Scholar
• Azzouz M, Ralph GS, Storkebaum E, Walmsley LE, Mitrophanous KA, Kingsman SM, . VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature. 2004;429:413–7.
   PubMed Web of Science ®Google Scholar
• Storkebaum E, Lambrechts D, Dewerchin M, Moreno-Murciano MP, Appelmans S, Oh H, . Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat Neurosci. 2005;8: 85–92.
   PubMed Web of Science ®Google Scholar
• Wang Y, Mao XO, Xie L, Banwait S, Marti HH, Greenberg DA, . Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice. J Neurosci. 2007;27:304–7.
   PubMed Web of Science ®Google Scholar
• Mazzini L, Fagioli F, Boccaletti R. Stem-cell therapy in amyotrophic lateral sclerosis. Lancet. 2004;364:1936–7.
   PubMed Web of Science ®Google Scholar
• Mazzini L, Fagioli F, Boccaletti R, Mareschi K, Oliveri G, Olivieri C, . Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;4:158–61.
   PubMed Web of Science ®Google Scholar
• Mazzini L, Mareschi K, Ferrero I, Vassallo E, Oliveri G, Boccaletti R, . Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis. Neurol Res. 2006;28:523–6.
   PubMed Web of Science ®Google Scholar
• Silani V, Cova L, Corbo M, Ciammola A, Polli E. Stem-cell therapy for amyotrophic lateral sclerosis. Lancet. 2004; 364:200–2.
   PubMed Web of Science ®Google Scholar
• Staats KA, Van Den Bosch L. Astrocytes in amyotrophic lateral sclerosis: direct effects on motor neuron survival. J Biol Phys. 2009;35:337–46.
   Google Scholar
• Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005;105:1815–22.
   PubMed Web of Science ®Google Scholar
• Le Blanc K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy. 2003;5:485–9.
   PubMed Web of Science ®Google Scholar
• Urdzikova L, Jendelova P, Glogarova K, Burian M, Hajek M, Sykova E. Transplantation of bone marrow stem cells as well as mobilization by granulocyte-colony stimulating factor promotes recovery after spinal cord injury in rats. J Neurotrauma. 2006;23:1379–91.
   PubMed Web of Science ®Google Scholar
• Li Y, Chen J, Chen XG, Wang L, Gautam SC, Xu YX, . Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology. 2002;59:514–23.
   PubMed Web of Science ®Google Scholar
• Zhang J, Li Y, Chen J, Yang M, Katakowski M, Lu M, . Expression of insulin-like growth factor 1 and receptor in ischemic rats treated with human marrow stromal cells. Brain Res. 2004;1030:19–27.
   PubMed Web of Science ®Google Scholar
• Basso DM, Beattie MS, Bresnaham JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma. 1995;12:1–12.
   PubMed Web of Science ®Google Scholar
• Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y. ‘Green mice’ as a source of ubiquitous green cells. FASEB Lett. 1997;407:313–9.
   PubMed Web of Science ®Google Scholar
• Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, . Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315–17.
   PubMed Web of Science ®Google Scholar
• Mouton PR. Principles and Practices of Unbiased Stereology: An Introduction for Bioscientists. The Johns Hopkins University Press, Baltimore, MD, USA; 2002.
   Google Scholar
• Bjugn R, Gundersen HJ. Estimate of the total number of neurons and glial and endothelial cells in the rat spinal cord by means of the optical dissector. J Comp Neurol. 1993 15;328: 406–14.
   Google Scholar
• Kostic V, Jackson-Lewis V, de Bilbao F, Dubois-Dauphin M, Przedborski S. Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science. 1997;277:559–62.
   PubMed Web of Science ®Google Scholar
• Li M, Ona VO, Guegan C, Chen M, Jackson-Lewis V, Andrews LJ, . Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science. 2000;288:335–9.
   PubMed Web of Science ®Google Scholar
• Vercelli A, Mereuta OM, Garbossa D, Muraca G, Mareschi K, Rustichelli D, . Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol Dis. 2008;31:395–405.
   PubMed Web of Science ®Google Scholar
• Bang OY, Lee JS, Lee PH, Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol. 2005;57:874–82.
   PubMed Web of Science ®Google Scholar
• Lescaudron L, Unni D, Dunbar GL. Autologous adult bone marrow stem cell transplantation in an animal model of Huntington's disease: behavioral and morphological outcomes. Int J Neurosci. 2003;113:945–56.
   PubMed Web of Science ®Google Scholar
• Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, . Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J. 2006;27:2775–83.
   PubMed Web of Science ®Google Scholar
• Garbuzova-Davis S, Sanberg CD, Kuzmin-Nichols N, Willing AE, Gemma C, Bickford PC, . Human umbilical cord blood treatment in a mouse model of ALS: optimization of cell dose. PLoS One. 2008;3:e2494.
   PubMed Web of Science ®Google Scholar
• Mitrecic D, Nicaise C, Gajovic S, Pochet R. Distribution, differentiation, and survival of intravenously administered neural stem cells in a rat model of amyotrophic lateral sclerosis. Cell Transplant. 2010;19:537–48.
   PubMed Web of Science ®Google Scholar
• Kim H, Kim HY, Choi MR, Hwang S, Nam KH, Kim HC, . Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice. Neurosci Lett. 2010;468:190–4.
   PubMed Web of Science ®Google Scholar
• Turner MR, Kiernan MC, Leigh PN, Talbot K. Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol. 2009;8: 94–109.
   PubMed Web of Science ®Google Scholar
• Boucherie C, Schafer S, Lavand'homme P, Maloteaux JM, Hermans E. Chimerization of astroglial population in the lumbar spinal cord after mesenchymal stem cell transplantation prolongs survival in a rat model of amyotrophic lateral sclerosis. J Neurosci Res. 2009;87:2034–46.
   PubMed Web of Science ®Google Scholar
• Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem. 2006;98:1076–84.
   PubMed Web of Science ®Google Scholar
• Crigler L, Robey RC, Asawachaicharn A, Gaupp D, Phinney DG. Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol. 2006;198: 54–64.
   PubMed Web of Science ®Google Scholar
• Hedlund E, Hefferan MP, Marsala M, Isacson O. Cell therapy and stem cells in animal models of motor neuron disorders. Eur J Neurosci. 2007;26:1721–37.
   PubMed Web of Science ®Google Scholar
• Garbuzova-Davis S, Saporta S, Haller E, Kolomey I, Bennett SP, Potter H, . Evidence of compromised blood–spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS. PLoS One. 2007;2:e1205.
   PubMed Web of Science ®Google Scholar
• Dewil M, dela Cruz VF, Van Den Bosch L, Robberecht W. Inhibition of p38 mitogen activated protein kinase activation and mutant SOD1(G93A)-induced motor neuron death. Neurobiol Dis. 2007;26:332–41.
   Google Scholar
• Rouaux C, Panteleeva I, Rene F, Gonzalez de Aguilar JL, Echaniz-Laguna A, Dupuis L, . Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model. J Neurosci. 2007;27:5535–45.
   PubMed Web of Science ®Google Scholar
• Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, . Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol. 2004;185:232–40.
   PubMed Web of Science ®Google Scholar
• Habisch HJ, Janowski M, Binder D, Kuzma-Kozakiewicz M, Widmann A, Habich A, . Intrathecal application of neuroectodermally converted stem cells into a mouse model of ALS: limited intraparenchymal migration and survival narrows therapeutic effects. J Neural Transm. 2007;114:1395–406.
   PubMed Web of Science ®Google Scholar